Given the insulin secretion stimulatory effect of BCAAs on β-cells [130], the high levels of BCAAs observed in obesity and T2DM may suggest a deleterious long-term effect or resistance to their function similar to what happens to FGF-21 in obesity [128,129,138]. This evidence concerns the gene FGF21 and obesity disorder.